Using artificial intelligence to predict abdominal aortic aneurysm shrinkage after stent placement
Official title: Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair With Artificial Intelligence
Run by Rijnstate Hospital · NCT06250998 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether artificial intelligence can help predict how much an abdominal aortic aneurysm will shrink after patients have a stent placed.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Rijnstate Hospital Academic / other |
| Locations | 5 sites (Arnhem, Non US/Canada and 4 other locations) |
| Trial ID | NCT06250998 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have undergone technically successful elective EVAR for unruptured infrarenal AAA.
✕Probably not a fit
Patients with ruptured or symptomatic AAA, or those treated with specific types of endografts not included in the study, will not benefit from this research.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify factors that contribute to successful treatment outcomes in patients who have undergone elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). The primary objective is to develop a predictive model for the shrinkage of AAA one year post-treatment using artificial intelligence. Eligible patients must have received specific types of endografts and have follow-up imaging available for analysis. The study will analyze preoperative imaging data to enhance understanding of aneurysm remodeling.
Why it matters
Potential benefit: If successful, this study could lead to improved predictions of aneurysm shrinkage, allowing for better patient management and outcomes.
How similar studies have gone: While the use of artificial intelligence in predicting treatment outcomes is a growing field, this specific approach to AAA shrinkage prediction is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years; * Elective, initially technically successful (as described by the ESVS guidelines11), infrarenal EVAR for unruptured infrarenal AAA; * Implanted endograft is a Gore Excluder, Medtronic Endurant, Cook Zenith, Cordis Incraft, Endologix AFX, Jotec E-Tegra, or Vascutek Anaconda endograft; * Follow-up of the AAA of at least one year with imaging of the same modality as the preoperative imaging; * Axial reconstructions of preoperative CT angiography available, preferably in the arterial phase and with 3 mm or smaller slice thickness. Exclusion Criteria: * Patients with ruptured or symptomatic AAA; * Patients that were treated with fenestrated or branched endografts, iliac branched devices, non-CE marked devices within trial setting, other endografts (EVAS cases) or chimney procedures; * Acute procedures; * Reintervention before one year follow-up; * Revision cases after previous open or endovascular aneurysm repair of an AAA;
Where it's running
-
Rijnstate Hospital
Arnhem, Non US/Canada, Netherlands Recruiting -
Amsterdam UMC
Amsterdam, Netherlands Recruiting -
Medisch Spectrum Twente
Enschede, Netherlands Recruiting -
Universitair Medisch Centrum Groningen
Groningen, Netherlands Recruiting -
Karolinksa Institutet
Stockholm, Sweden Not yet recruiting
Study contacts
- Study coordinator: Rianne E van Rijswijk, MSc
- Email: contact@radarconsortium.com
- Phone: 0031880057282
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heli-FX EndoAnchor system in abdominal aortic aneurysm patients in China
This study tests whether the Heli-FX EndoAnchor device can safely and effectively help seal and fix AAA patients at high risk of endoleaks or migration after repair.
-
TUVA BX and iCover stent grafts used in BEVAR for complex aortic aneurysms
This study looks at whether the TUVA BX and iCover stent grafts used during BEVAR procedures are safe and perform well in real-world patients with complex abdominal or thoracoabdominal aneurysms.
-
Retreatment with the Nectero EAST System for abdominal aortic aneurysm
This will try retreatment with the Nectero EAST System to repair infrarenal abdominal aortic aneurysms in adults who previously received the device under the initial protocol.
-
Abdominal CT offered alongside lung screening for people who have smoked
We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.
-
Observational registry for patients treated with GORE® endovascular devices for abdominal aortic aneurysms
This study is tracking patients who have been treated with GORE® devices for abdominal aortic aneurysms to see how they do over the next 10 years.
-
Evaluating outcomes of endovascular abdominal aortic aneurysm repair
This study is testing two different devices for repairing abdominal aortic aneurysms to see which one works better for patients over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.